74 false false false false true false false false false false false true false false false false true false No description of principal activity 2024-12-01 Sage Accounts Production Advanced 2024 - FRS102_2024 1,169,191 32,665 1,039,815 1,039,815 1,173,870 118,354 1,292,224 xbrli:pure xbrli:shares iso4217:GBP 03273230 2024-12-01 2025-11-30 03273230 2025-11-30 03273230 2024-11-30 03273230 2023-12-01 2024-11-30 03273230 2024-11-30 03273230 2023-11-30 03273230 bus:RegisteredOffice 2024-12-01 2025-11-30 03273230 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 03273230 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 03273230 bus:Director1 2024-12-01 2025-11-30 03273230 bus:Director2 2024-12-01 2025-11-30 03273230 bus:CompanySecretary1 2024-12-01 2025-11-30 03273230 core:WithinOneYear 2025-11-30 03273230 core:WithinOneYear 2024-11-30 03273230 core:LandBuildings 2024-11-30 03273230 core:FurnitureFittings 2024-11-30 03273230 core:LandBuildings 2025-11-30 03273230 core:FurnitureFittings 2025-11-30 03273230 core:DeferredTaxation 2024-12-01 2025-11-30 03273230 core:LandBuildings 2024-12-01 2025-11-30 03273230 core:FurnitureFittings 2024-12-01 2025-11-30 03273230 core:RevaluationReserve 2023-12-01 2024-11-30 03273230 core:RetainedEarningsAccumulatedLosses 2023-12-01 2024-11-30 03273230 core:RetainedEarningsAccumulatedLosses 2024-12-01 2025-11-30 03273230 core:UKTax 2024-12-01 2025-11-30 03273230 core:UKTax 2023-12-01 2024-11-30 03273230 core:ShareCapital 2025-11-30 03273230 core:ShareCapital 2024-11-30 03273230 core:RevaluationReserve 2025-11-30 03273230 core:RevaluationReserve 2024-11-30 03273230 core:RetainedEarningsAccumulatedLosses 2025-11-30 03273230 core:RetainedEarningsAccumulatedLosses 2024-11-30 03273230 core:ShareCapital 2023-11-30 03273230 core:RevaluationReserve 2023-11-30 03273230 core:RetainedEarningsAccumulatedLosses 2023-11-30 03273230 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 03273230 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-11-30 03273230 core:AcceleratedTaxDepreciationDeferredTax 2025-11-30 03273230 core:AcceleratedTaxDepreciationDeferredTax 2024-11-30 03273230 core:LandBuildings 2024-11-30 03273230 core:FurnitureFittings 2024-11-30 03273230 core:DeferredTaxation 2024-11-30 03273230 core:DeferredTaxation 2025-11-30 03273230 bus:LeadAgentIfApplicable 2023-12-01 2024-11-30 03273230 bus:MediumEntities 2024-12-01 2025-11-30 03273230 bus:Audited 2024-12-01 2025-11-30 03273230 bus:Medium-sizedCompaniesRegimeForAccounts 2024-12-01 2025-11-30 03273230 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 03273230 bus:FullAccounts 2024-12-01 2025-11-30 03273230 bus:OrdinaryShareClass1 2025-11-30 03273230 bus:OrdinaryShareClass1 2024-11-30
COMPANY REGISTRATION NUMBER: 03273230
Topcare Limited
Financial Statements
For the year ended
30 November 2025
Topcare Limited
Financial Statements
Year ended 30 November 2025
Contents
Page
Officers and professional advisers
1
Strategic report
2
Directors' report
3
Independent auditor's report to the members
5
Statement of comprehensive income
10
Statement of financial position
11
Statement of changes in equity
13
Notes to the financial statements
14
Topcare Limited
Officers and Professional Advisers
The board of directors
B N Lukka
N J Lukka
Company secretary
A N Lukka
Registered office
Macneil House
9-17 Lodge Lane
London
N12 8JH
Auditor
Streets Audit LLP
Chartered accountants & statutory auditor
Enterprise House
38 Tyndall Court
Commerce Road
Lynch Wood
Peterborough
Cambridgeshire
PE2 6LR
Bankers
Handelsbanken
2nd Floor Hathaway House
Popes Drive
Finchley Central
London
N3 1QF
Topcare Limited
Strategic Report
Year ended 30 November 2025
The directors present the strategic report for the year ended 30 November 2025. Fair review of the business The principal activity of the company continues to be the provision of nursing home facilities for the elderly. During the year, the directors have completed a restructure to form a group and the company is now part of the LCH Care Group Limited. The company made a pre-tax profit of £1.7m (2024: £0.3m) for the year on a turnover of £4.6m (2024: £4.5m). At 30 November 2025 the company had net assets of £19.0m (2024: £17.8m). Principal risks and uncertainties The directors recognise that within the business there are a number of risks which may affect the performance of the company. These risks are subject to regular review and, where appropriate, processes are established to minimise the level of exposure. Regulatory - the company's nursing home is regulated by the Care Quality Commission and is exposed to adverse findings that the Commission may raise. The company ensures that the nursing home is run to a high standard and to-date no such adverse findings have been reported. Financial risk - the company is exposed to financial risk through its assets and liabilities. The key financial risk is that, in the current climate, the proceeds from its assets may not be sufficient to fund the obligations from liabilities as they fall due. The most important components of financial risk are: 1) Credit risk - the company continues to minimise commercial credit risk and has not suffered unduly from bad debts. 2) Interest rate risk - the company's borrowings are on a variable rate basis and the company is exposed to potential increases in interest rates. The company continues to monitor its interest obligations and its investment portfolio to ensure that future increases in interest rates will not unduly affect the performance of the business. Key performance indicators In the opinion of the directors, occupancy percentage and average fee per resident are considered key performance indicators when assessing business performance and is reviewed monthly by the management team, with both having remained in line with the directors' expectations, in the current climate. Future developments The directors continue to monitor its key performance metrics whilst maintaining care quality its home.
This report was approved by the board of directors on 15 July 2026 and signed on behalf of the board by:
B N Lukka
Director
Registered office:
Macneil House
9-17 Lodge Lane
London
N12 8JH
Topcare Limited
Directors' Report
Year ended 30 November 2025
The directors present their report and the financial statements of the company for the year ended 30 November 2025 .
Directors
The directors who served the company during the year were as follows:
B N Lukka
N J Lukka
Dividends
The directors do not recommend the payment of a dividend.
Future developments
The directors have made disclosures on future developments and financial instruments in the strategic report.
Directors' responsibilities statement
The directors are responsible for preparing the strategic report, directors' report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: - select suitable accounting policies and then apply them consistently; - make judgments and accounting estimates that are reasonable and prudent; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information. The auditor is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.
This report was approved by the board of directors on 15 July 2026 and signed on behalf of the board by:
B N Lukka
Director
Registered office:
Macneil House
9-17 Lodge Lane
London
N12 8JH
Topcare Limited
Independent Auditor's Report to the Members of Topcare Limited
Year ended 30 November 2025
Opinion
We have audited the financial statements of Topcare Limited (the 'company') for the year ended 30 November 2025 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial statements: - give a true and fair view of the state of the company's affairs as at 30 November 2025 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows: - the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations; - we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the company and sector in which it operates; - we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006 and taxation legislation, Care Home legislation and health and safety legislation; - we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and - identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit. We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by: - making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and - considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations. To address the risk of fraud through management bias and override of controls, we: - performed analytical procedures to identify any unusual or unexpected relationships; - tested journal entries to identify unusual transactions; - assessed whether judgements and assumptions made in determining the accounting estimates set out in Note 3 were indicative of potential bias; and - investigated the rationale behind significant or unusual transactions. In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to: - agreeing financial statement disclosures to underlying supporting documentation; - reading the minutes of meetings of those charged with governance; - inquiring of management as to actual and potential litigation and claims; and - reviewing correspondence with HMRC, relevant regulators and the company's legal advisors. There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to inquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion. As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also: - Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. - Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control. - Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors. - Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern. - Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Use of our report
This report is made solely to the company's members, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Jonathan Day
(Senior Statutory Auditor)
For and on behalf of
Streets Audit LLP
Chartered accountants & statutory auditor
Enterprise House
38 Tyndall Court
Commerce Road
Lynch Wood
Peterborough
Cambridgeshire
PE2 6LR
15 July 2026
Topcare Limited
Statement of Comprehensive Income
Year ended 30 November 2025
2025
2024
Note
£
£
Turnover
4
4,655,518
4,450,046
Cost of sales
2,729,469
2,560,387
------------
------------
Gross profit
1,926,049
1,889,659
Administrative expenses
348,102
401,551
------------
------------
Operating profit
5
1,577,947
1,488,108
Income from other fixed asset investments
8
180,956
Other interest receivable and similar income
173,597
87,027
Amounts written back to investments
9
1,039,815
Interest payable and similar expenses
10
67,372
430,110
------------
------------
Profit before taxation
1,684,172
286,166
Tax on profit
11
514,981
318,831
------------
---------
Profit/(loss) for the financial year and total comprehensive income
1,169,191
( 32,665)
------------
---------
All the activities of the company are from continuing operations.
Topcare Limited
Statement of Financial Position
30 November 2025
2025
2024
Note
£
£
£
Fixed assets
Tangible assets
12
7,609,585
7,695,779
Current assets
Debtors
14
12,051,719
2,578,834
Cash at bank and in hand
1,190,169
12,111,210
-------------
-------------
13,241,888
14,690,044
Creditors: amounts falling due within one year
15
578,325
3,400,220
-------------
-------------
Net current assets
12,663,563
11,289,824
-------------
-------------
Total assets less current liabilities
20,273,148
18,985,603
Provisions
Taxation including deferred tax
16
1,292,224
1,173,870
-------------
-------------
Net assets
18,980,924
17,811,733
-------------
-------------
Topcare Limited
Statement of Financial Position (continued)
30 November 2025
2025
2024
Note
£
£
£
Capital and reserves
Called up share capital
19
20,000
20,000
Revaluation reserve
20
5,144,897
5,144,897
Profit and loss account
20
13,816,027
12,646,836
-------------
-------------
Shareholders funds
18,980,924
17,811,733
-------------
-------------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the medium companies regime.
These financial statements were approved by the board of directors and authorised for issue on 15 July 2026 , and are signed on behalf of the board by:
B N Lukka
Director
Company registration number: 03273230
Topcare Limited
Statement of Changes in Equity
Year ended 30 November 2025
Called up share capital
Revaluation reserve
Profit and loss account
Total
£
£
£
£
At 1 December 2023
20,000
5,249,528
12,574,870
17,844,398
Loss for the year
( 32,665)
( 32,665)
Other comprehensive income for the year:
Reclassification from revaluation reserve to profit and loss account
( 104,631)
104,631
--------
------------
-------------
-------------
Total comprehensive income for the year
( 104,631)
71,966
( 32,665)
At 30 November 2024
20,000
5,144,897
12,646,836
17,811,733
Profit for the year
1,169,191
1,169,191
--------
------------
-------------
-------------
Total comprehensive income for the year
1,169,191
1,169,191
--------
------------
-------------
-------------
At 30 November 2025
20,000
5,144,897
13,816,027
18,980,924
--------
------------
-------------
-------------
Topcare Limited
Notes to the Financial Statements
Year ended 30 November 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Macneil House, 9-17 Lodge Lane, London, N12 8JH.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. Its financial statements are consolidated into the financial statements of LCH Care Group Ltd which can be obtained from Companies House. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the company. (b) Disclosures in respect of financial instruments have not been presented. (d) No disclosure has been given for the aggregate remuneration of key management personnel.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements are as follows: Valuation of land and buildings The company carries its property used in the business at fair value, with changes in fair value being recognised through other comprehensive income. The company has consulted with external valuers to ascertain the fair value of the land and buildings. The valuation of the company’s land and buildings is inherently subjective due to, among other factors, the individual nature, location and condition of the nursing home premises. The land element of the land and buildings is also a subjective judgement. As a result the valuation is subject to a degree of uncertainty. The most recent external valuation took place in January 2021 and was reflected in the 2020 financial statements. Since then the Directors have assessed the market value of the property each year and deem the net book value to be materially in line with the market value at the year-end date. Deferred tax has been recognised on revalued property, based on the estimated fair value at the year-end date. Related Party Debtors Included in the accounts are amounts due from companies under the control of Mr N J Lukka and members of his close family. The directors have considered the quality and performance of the underlying assets and deemed these amounts to be recoverable and not impaired. Depreciation Depreciation is recognised over the estimated useful life of assets, please see the accounting policy for further details.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all material timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Land and buildings
-
2% Straight line (excluding land)
Fixtures and fittings
-
15% Reducing balance
Excess depreciation between revalued land and buildings and historical cost is transferred between the profit and loss reserve and revaluation reserve. The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Income from investments is recorded on a receipts basis.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Financial instruments
The company holds basic financial instruments as defined in FRS102. The financial assets and financial liabilities of the company and their measurement basis are as follows: Financial assets - trade and other debtors are basic financial instruments and are debt instruments measured at amortised cost. Prepayments are not financial instruments. Cash at bank is classified as a basic financial instrument and is measured at amortised cost. Financial liabilities - trade creditors, accruals and other creditors are financial instruments, and are measured at amortised cost. Taxation and social security are not included in the financial instruments disclosure definition.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided.
4. Turnover
Turnover arises from:
2025
2024
£
£
Nursing home fees
4,655,518
4,450,046
------------
------------
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5. Operating profit
Operating profit or loss is stated after charging:
2025
2024
£
£
Depreciation of tangible assets
184,619
178,498
Impairment of trade debtors
88,851
---------
---------
6. Auditor's remuneration
2025
2024
£
£
Fees payable for the audit of the financial statements
7,500
12,000
-------
--------
7. Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:
2025
2024
No.
No.
Administration and care staff
74
76
----
----
The aggregate payroll costs incurred during the year, relating to the above, were:
2025
2024
£
£
Wages and salaries
2,168,849
2,058,620
Social security costs
250,154
187,884
Other pension costs
45,103
40,090
------------
------------
2,464,106
2,286,594
------------
------------
8. Income from other fixed asset investments
2025
2024
£
£
Income from other fixed asset investments
180,956
----
---------
9. Amounts written back to investments
2025
2024
£
£
Impairment of other fixed asset investments
1,039,815
----
------------
10. Interest payable and similar expenses
2025
2024
£
£
Interest on banks loans and overdrafts
67,372
430,110
--------
---------
11. Tax on profit
Major components of tax expense
2025
2024
£
£
Current tax:
UK current tax expense
443,071
309,495
Adjustments in respect of prior periods
( 46,444)
---------
---------
Total current tax
396,627
309,495
---------
---------
Deferred tax:
Origination and reversal of timing differences
118,354
9,336
---------
---------
Tax on profit
514,981
318,831
---------
---------
Reconciliation of tax expense
The tax assessed on the profit on ordinary activities for the year is higher than (2024: higher than) the standard rate of corporation tax in the UK of 25 % (2024: 25 %).
2025
2024
£
£
Profit on ordinary activities before taxation
1,684,172
286,166
------------
---------
Profit on ordinary activities by rate of tax
421,043
71,542
Adjustment to tax charge in respect of prior periods
61,084
Effect of expenses not deductible for tax purposes
226
259,954
Effect of capital allowances and depreciation
32,628
32,574
Effect of revenue exempt from tax
( 45,239)
------------
---------
Tax on profit
514,981
318,831
------------
---------
12. Tangible assets
Land and buildings
Fixtures and fittings
Total
£
£
£
Cost
At 1 December 2024
7,935,962
1,149,245
9,085,207
Additions
10,860
87,565
98,425
------------
------------
------------
At 30 November 2025
7,946,822
1,236,810
9,183,632
------------
------------
------------
Depreciation
At 1 December 2024
513,327
876,101
1,389,428
Charge for the year
130,513
54,106
184,619
------------
------------
------------
At 30 November 2025
643,840
930,207
1,574,047
------------
------------
------------
Carrying amount
At 30 November 2025
7,302,982
306,603
7,609,585
------------
------------
------------
At 30 November 2024
7,422,635
273,144
7,695,779
------------
------------
------------
Included within freehold property is land valued at £1.4m which has not been depreciated.
Tangible assets held at valuation
The carrying value of land and buildings was revalued as at 30 November 2020. The revaluation was based on a valuation report prepared on 7 January 2021 by a third party RICS certified property consultant. Their valuation was based on the special assumption that the land and buildings are fully equipped as operational entities and valued having regard to trading potential, as at the date of valuation. As at 30 November 2025 the directors believe that the carrying value of the land and buildings correctly reflect their fair value. If revalued assets were stated on an historical cost basis rather than a fair value basis, the carrying amounts included would be £953k (2024: £973k), being cost of £1.5m (2024: £1.5m) and depreciation of £568k (2024: £538k).
13. Investments
Other investments other than loans
£
Cost
At 1 December 2024 and 30 November 2025
1,039,815
------------
Impairment
At 1 December 2024 and 30 November 2025
1,039,815
------------
Carrying amount
At 30 November 2025
------------
At 30 November 2024
------------
The company had an investment in Radia Estates Ltd. The company owned 3% of the shareholding and does not have control of the investment. In the prior year this was fully impaired based on the Directors expectation of recoverability.
14. Debtors
2025
2024
£
£
Trade debtors
151,371
275,922
Amounts owed by group undertakings
11,794,387
2,250,000
Prepayments and accrued income
44,755
28,891
Corporation tax repayable
40,931
Directors loan account
2,682
Other debtors
20,275
21,339
-------------
------------
12,051,719
2,578,834
-------------
------------
15. Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
2,468,673
Trade creditors
224,269
308,607
Accruals and deferred income
113,166
144,324
Corporation tax
219,495
Social security and other taxes
54,812
44,957
Other creditors
186,078
214,164
---------
------------
578,325
3,400,220
---------
------------
16. Provisions
Deferred tax (note 17)
£
At 1 December 2024
1,173,870
Additions
118,354
------------
At 30 November 2025
1,292,224
------------
17. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2025
2024
£
£
Included in provisions (note 16)
1,292,224
1,173,870
------------
------------
The deferred tax account consists of the tax effect of timing differences in respect of:
2025
2024
£
£
Accelerated capital allowances
53,924
43,942
Short term timing differences
106,676
(1,696)
Capital gains
1,131,624
1,131,624
------------
------------
1,292,224
1,173,870
------------
------------
18. Employee benefits
Defined contribution plans
The amount recognised in profit or loss as an expense in relation to defined contribution plans was £ 45,103 (2024: £ 40,090 ).
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
19. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 1 each
20,000
20,000
20,000
20,000
--------
--------
--------
--------
20. Reserves
Revaluation reserve - This reserve records the value of asset revaluations and fair value movements on assets recognised in other comprehensive income. Profit and loss account - This reserve records retained earnings and accumulated losses.
21. Directors' advances, credits and guarantees
At the year end the company was owed £nil (2024: £2,682) by N J Lukka . No interest was charged and there is no fixed repayment date for the loan.
22. Related party transactions
The company has taken advantage of the exemption available under FRS 102 not to disclose transactions and balances with other group companies.
23. Controlling party
The companies immediate parent is LCH Care Group Ltd. The parent company is registered in England and Wales and is has a registered office at Macneil House, 9-17 Lodge Lane, London, N12 8JH and prepares consolidated accounts which are available from Companies House. The directors consider the ultimate controlling parties are the Trustees of the LCH Care Group Ltd Discretionary Trust.